Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Stoke Therapeutics (STOK) Research & Development: 2022-2024

Historic Research & Development for Stoke Therapeutics (STOK) over the last 3 years, with Dec 2024 value amounting to $89.1 million.

  • Stoke Therapeutics' Research & Development rose 69.76% to $37.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $119.7 million, marking a year-over-year increase of 36.76%. This contributed to the annual value of $89.1 million for FY2024, which is 8.39% up from last year.
  • Per Stoke Therapeutics' latest filing, its Research & Development stood at $89.1 million for FY2024, which was up 8.39% from $82.2 million recorded in FY2023.
  • In the past 5 years, Stoke Therapeutics' Research & Development registered a high of $89.1 million during FY2024, and its lowest value of $77.8 million during FY2022.
  • In the last 3 years, Stoke Therapeutics' Research & Development had a median value of $82.2 million in 2023 and averaged $83.1 million.
  • Data for Stoke Therapeutics' Research & Development shows a peak YoY increased of 8.39% (in 2024) over the last 5 years.
  • Over the past 3 years, Stoke Therapeutics' Research & Development (Yearly) stood at $77.8 million in 2022, then grew by 5.65% to $82.2 million in 2023, then increased by 8.39% to $89.1 million in 2024.